Use of Fish Oils to Reduce the Frequency and Duration of Episodes of Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation.
The purpose of this study is to investigate whether fish oil supplements may reduce the frequency and duration of paroxysmal atrial fibrillation episodes.
Atrial fibrillation is a heart condition which effects a large percentage of the population .
Atrial fibrillation is a condition frequently experienced by people who have had pacemakers inserted .
Certain Pacemakers have sophisticated monitoring features that are able to recognise episodes of atrial fibrillation.
Fish oil supplements may be of benefit to patients with heart problems.Recent evidence suggests that fish oils may be beneficial to patients with rhythm disturbances.
By interrogating pacemakers this study will investigate the effect of fish oil supplements on the frequency and duration of episodes of atrial fibrillation.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
- Atrial tachycardia and atrial fibrillation burden [ Time Frame: 18 months ] [ Designated as safety issue: No ]
- Frequency and duration of atrial tachycardia/fibrillation episodes [ Time Frame: 18 months ] [ Designated as safety issue: No ]
- Safety and tolerability of fish oil [ Time Frame: 18 months ] [ Designated as safety issue: Yes ]
|Study Start Date:||December 2003|
|Study Completion Date:||January 2013|
|Primary Completion Date:||January 2013 (Final data collection date for primary outcome measure)|
Experimental: Fish oil
Patients prescribed 6g/day of fish oil containing total 1.8 g of EPA+DHA in a 1.5:1 ratio
|Drug: Fish oil|
No Intervention: Control
No fish oil exposure
Please refer to this study by its ClinicalTrials.gov identifier: NCT00232245
|Royal Melbourne hospital|
|Melbourne, Victoria, Australia, 3050|
|Principal Investigator:||Paul Sparks||Melbourne Health|